Coenzyme Q10 instilled as eye drops on the cornea reaches the retina and protects retinal layers from apoptosis in a mouse model of kainate-induced retinal damage.

PURPOSE To evaluate if coenzyme Q10 (CoQ10) can protect retinal ganglion cells (RGCs) from apoptosis and, when instilled as eye drops on the cornea, if it can reach the retina and exert its antiapoptotic activity in this area in a mouse model of kainate (KA)-induced retinal damage. METHODS Rat primary or cultured RGCs were subjected to glutamate (50 μM) or chemical hypoxia (Antimycin A, 200 μM) or serum withdrawal (FBS, 0.5%) in the presence or absence of CoQ10 (10 μM). Cell viability was evaluated by light microscopy and fluorescence-activated cell sorting analyses. Apoptosis was evaluated by caspase 3/7 activity and mitochondrion depolarization tetramethylrhodamine ethyl ester analysis. CoQ10 transfer to the retina following its instillation as eye drops on the cornea was quantified by HPLC. Retinal protection by CoQ10 (10 μM) eye drops instilled on the cornea was then evaluated in a mouse model of KA-induced excitotoxic retinal cell apoptosis by cleaved caspase 3 immunohistofluorescence, caspase 3/7 activity assays, and quantification of inhibition of RGC loss. RESULTS CoQ10 significantly increased viable cells by preventing RGC apoptosis. Furthermore, when topically applied as eye drops to the cornea, it reached the retina, thus substantially increasing local CoQ10 concentration and protecting retinal layers from apoptosis. CONCLUSIONS The ability of CoQ10 eye drops to protect retinal cells from apoptosis in the mouse model of KA-induced retinal damage suggests that topical CoQ10 may be evaluated in designing therapies for treating apoptosis-driven retinopathies.

[1]  S. Chintala,et al.  Inhibition of Reactive Gliosis Attenuates Excitotoxicity-Mediated Death of Retinal Ganglion Cells , 2011, PloS one.

[2]  E. Verdaguer,et al.  Antiapoptotic drugs: a therapautic strategy for the prevention of neurodegenerative diseases. , 2011, Current pharmaceutical design.

[3]  X. Leverve,et al.  Ubiquinone Analogs: A Mitochondrial Permeability Transition Pore-Dependent Pathway to Selective Cell Death , 2010, PloS one.

[4]  Thomas V. Johnson,et al.  Rodent models of glaucoma , 2010, Brain Research Bulletin.

[5]  A. Pinna,et al.  Coenzyme Q10 vitreous levels after administration of coenzyme Q10 eyedrops in patients undergoing vitrectomy , 2009, Acta ophthalmologica.

[6]  M. Vidal-Sanz,et al.  Brn3a as a marker of retinal ganglion cells: qualitative and quantitative time course studies in naive and optic nerve-injured retinas. , 2009, Investigative ophthalmology & visual science.

[7]  I. Washington,et al.  Coenzyme Q10 in the human retina. , 2009, Investigative ophthalmology & visual science.

[8]  H. Hara,et al.  Coenzyme Q10 protects retinal cells against oxidative stress in vitro and in vivo , 2008, Brain Research.

[9]  J. Smeitink,et al.  Life cell quantification of mitochondrial membrane potential at the single organelle level , 2008, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[10]  E. Fazzi,et al.  Rational basis for the development of coenzyme Q10 as a neurotherapeutic agent for retinal protection. , 2008, Progress in brain research.

[11]  T. Harada,et al.  The potential role of glutamate transporters in the pathogenesis of normal tension glaucoma. , 2007, The Journal of clinical investigation.

[12]  P. Bernardi,et al.  The mitochondrial permeability transition pore and its involvement in cell death and in disease pathogenesis , 2007, Apoptosis.

[13]  B. Antonsson,et al.  A tale of two mitochondrial channels, MAC and PTP, in apoptosis , 2007, Apoptosis.

[14]  C. Nucci,et al.  Retinal damage caused by high intraocular pressure-induced transient ischemia is prevented by coenzyme Q10 in rat. , 2007, International review of neurobiology.

[15]  J. Féher,et al.  Mitochondrial alterations of retinal pigment epithelium in age-related macular degeneration , 2006, Neurobiology of Aging.

[16]  E. Fazzi,et al.  Neurochemical evidence to implicate elevated glutamate in the mechanisms of high intraocular pressure (IOP)-induced retinal ganglion cell death in rat. , 2005, Neurotoxicology.

[17]  S. Chintala,et al.  Plasminogen activators promote excitotoxicity‐induced retinal damage , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[18]  D. Henson,et al.  Preventing blindness from glaucoma , 2005, BMJ : British Medical Journal.

[19]  A. Hara,et al.  Tissue type plasminogen activator facilitates NMDA-receptor-mediated retinal apoptosis through an independent fibrinolytic cascade. , 2005, Investigative ophthalmology & visual science.

[20]  Philip P. Chen.  Risk and risk factors for blindness from glaucoma , 2004, Current opinion in ophthalmology.

[21]  G. Mannino,et al.  Mitotropic Compounds for the Treatment of Age-Related Macular Degeneration , 2003, Ophthalmologica.

[22]  Ewa Witort,et al.  Coenzyme Q10 Prevents Apoptosis by Inhibiting Mitochondrial Depolarization Independently of Its Free Radical Scavenging Property* , 2003, Journal of Biological Chemistry.

[23]  L. Papucci,et al.  The Mechanisms of Apoptosis in Biology and Medicine: A New Focus for Ophthalmology , 2003, European journal of ophthalmology.

[24]  Sergio Capaccioli,et al.  Concomitant effect of topical ubiquinone Q10 and vitamin E to prevent keratocyte apoptosis after excimer laser photoablation in rabbits. , 2002, Journal of refractive surgery.

[25]  D. Lynch,et al.  Excitotoxicity: perspectives based on N-methyl-D-aspartate receptor subtypes. , 2002, The Journal of pharmacology and experimental therapeutics.

[26]  Mark P. Mattson,et al.  Apoptosis in neurodegenerative disorders , 2000, Nature Reviews Molecular Cell Biology.

[27]  X. Leverve,et al.  Three Classes of Ubiquinone Analogs Regulate the Mitochondrial Permeability Transition Pore through a Common Site* , 2000, The Journal of Biological Chemistry.

[28]  S. Siano,et al.  Prevention of Corneal Keratocyte Apoptosis after Argon Fluoride Excimer Laser Irradiation with the Free Radical Scavenger Ubiquinone Q10 , 2000, European journal of ophthalmology.

[29]  N. Schiavone,et al.  Ganglionic cell apoptogenesis in glaucoma , 1999 .

[30]  S. Sharma,et al.  MK801—a neuroprotectant in rat hypertensive eyes , 1998, Brain Research.

[31]  S. Lipton,et al.  Molecular basis of glutamate toxicity in retinal ganglion cells , 1997, Vision Research.

[32]  T. Urano,et al.  Comparison of changes in serotonergic measures in whole blood or plasma and brain in rats given nicotine and/or stresses. , 1996, Polish journal of pharmacology.